{"count":221416,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=479","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=477","results":[{"created":"2024-03-22T14:47:35.689981+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2451","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HTRA2 were changed from  to 3-methylglutaconic aciduria, type VIII, MIM# 617248","entity_name":"HTRA2","entity_type":"gene"},{"created":"2024-03-22T14:46:55.745482+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2450","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: HTRA2 were set to ","entity_name":"HTRA2","entity_type":"gene"},{"created":"2024-03-22T14:46:18.778305+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2449","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: HTRA2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"HTRA2","entity_type":"gene"},{"created":"2024-03-22T14:45:13.288434+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2448","user_name":"Zornitza Stark","item_type":"entity","text":"changed review comment from: Multiple families reported with bi-allelic variants in HSPD1 and hypomyelinating leukodystrophy. Supportive mouse model. In addition, two unrelated individuals reported with same de novo missense p.Leu47Val and leukodystrophy.\r\n\r\nIn addition, mono-allelic variants found in families with SPG.; to: Multiple families reported with bi-allelic variants in HSPD1 and hypomyelinating leukodystrophy. Supportive mouse model. In addition, two unrelated individuals reported with same de novo missense p.Leu47Val and leukodystrophy.\r\n\r\nIn addition, mono-allelic variants found in families with SPG, not relevant to this panel.","entity_name":"HSPD1","entity_type":"gene"},{"created":"2024-03-22T14:45:00.612518+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2448","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: HSPD1: Changed phenotypes: Leukodystrophy, hypomyelinating, 4, MIM# 612233; Changed mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"HSPD1","entity_type":"gene"},{"created":"2024-03-22T14:44:47.194360+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2448","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HSPD1 as ready","entity_name":"HSPD1","entity_type":"gene"},{"created":"2024-03-22T14:44:47.183728+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2448","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hspd1 has been classified as Green List (High Evidence).","entity_name":"HSPD1","entity_type":"gene"},{"created":"2024-03-22T14:44:32.874512+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2448","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HSPD1 were changed from  to Leukodystrophy, hypomyelinating, 4, MIM# 612233","entity_name":"HSPD1","entity_type":"gene"},{"created":"2024-03-22T14:43:52.823584+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2447","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: HSPD1 was changed from BOTH monoallelic and biallelic, autosomal or pseudoautosomal to BIALLELIC, autosomal or pseudoautosomal","entity_name":"HSPD1","entity_type":"gene"},{"created":"2024-03-22T14:43:30.059169+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2446","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: HSPD1 were set to ","entity_name":"HSPD1","entity_type":"gene"},{"created":"2024-03-22T14:42:58.680990+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2445","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: HSPD1 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"HSPD1","entity_type":"gene"},{"created":"2024-03-22T14:42:05.771678+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2444","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HSD17B4 as ready","entity_name":"HSD17B4","entity_type":"gene"},{"created":"2024-03-22T14:42:05.763048+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2444","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hsd17b4 has been classified as Green List (High Evidence).","entity_name":"HSD17B4","entity_type":"gene"},{"created":"2024-03-22T14:41:56.010590+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2444","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HSD17B4 were changed from  to D-bifunctional protein deficiency, AR (MIM#261515); Perrault syndrome 1, AR (MIM#233400)","entity_name":"HSD17B4","entity_type":"gene"},{"created":"2024-03-22T14:41:30.640258+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2443","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: HSD17B4 were set to ","entity_name":"HSD17B4","entity_type":"gene"},{"created":"2024-03-22T14:41:00.344158+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2442","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: HSD17B4 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"HSD17B4","entity_type":"gene"},{"created":"2024-03-22T14:40:00.983438+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2441","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HRAS as ready","entity_name":"HRAS","entity_type":"gene"},{"created":"2024-03-22T14:40:00.972755+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2441","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hras has been classified as Green List (High Evidence).","entity_name":"HRAS","entity_type":"gene"},{"created":"2024-03-22T14:39:42.621473+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2441","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HRAS were changed from Costello syndrome, MIM# 218040 to Costello syndrome, MIM# 218040","entity_name":"HRAS","entity_type":"gene"},{"created":"2024-03-22T14:39:12.396831+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2440","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HRAS were changed from  to Costello syndrome, MIM# 218040","entity_name":"HRAS","entity_type":"gene"},{"created":"2024-03-22T14:38:25.098432+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2439","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: HRAS were set to ","entity_name":"HRAS","entity_type":"gene"},{"created":"2024-03-22T14:37:58.962022+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2438","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of pathogenicity for gene: HRAS was changed from  to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments","entity_name":"HRAS","entity_type":"gene"},{"created":"2024-03-22T14:37:28.578192+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2437","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: HRAS was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"HRAS","entity_type":"gene"},{"created":"2024-03-22T14:36:10.296548+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2436","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HMGCL as ready","entity_name":"HMGCL","entity_type":"gene"},{"created":"2024-03-22T14:36:10.285851+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2436","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hmgcl has been classified as Green List (High Evidence).","entity_name":"HMGCL","entity_type":"gene"},{"created":"2024-03-22T14:36:01.691032+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2436","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HMGCL were changed from  to HMG-CoA lyase deficiency, MIM# 246450","entity_name":"HMGCL","entity_type":"gene"},{"created":"2024-03-22T14:35:12.952556+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2435","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: HMGCL were set to ","entity_name":"HMGCL","entity_type":"gene"},{"created":"2024-03-22T14:34:35.622244+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2434","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: HMGCL was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"HMGCL","entity_type":"gene"},{"created":"2024-03-22T14:33:25.227829+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2433","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HLCS as ready","entity_name":"HLCS","entity_type":"gene"},{"created":"2024-03-22T14:33:25.220474+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2433","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hlcs has been classified as Green List (High Evidence).","entity_name":"HLCS","entity_type":"gene"},{"created":"2024-03-22T14:33:21.696852+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2433","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HLCS were changed from  to Holocarboxylase synthetase deficiency, MIM# 253270","entity_name":"HLCS","entity_type":"gene"},{"created":"2024-03-22T14:31:59.415697+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2432","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: HLCS were set to ","entity_name":"HLCS","entity_type":"gene"},{"created":"2024-03-22T14:31:20.450270+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2431","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: HLCS was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"HLCS","entity_type":"gene"},{"created":"2024-03-22T14:30:32.819978+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2430","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HEXB as ready","entity_name":"HEXB","entity_type":"gene"},{"created":"2024-03-22T14:30:32.808324+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2430","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hexb has been classified as Green List (High Evidence).","entity_name":"HEXB","entity_type":"gene"},{"created":"2024-03-22T14:30:26.781125+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2430","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HEXB were changed from  to Sandhoff disease, infantile, juvenile, and adult forms, MIM# 268800; MONDO:0010006","entity_name":"HEXB","entity_type":"gene"},{"created":"2024-03-22T14:29:46.388755+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2429","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: HEXB was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"HEXB","entity_type":"gene"},{"created":"2024-03-22T14:28:51.973830+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2428","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HEXA as ready","entity_name":"HEXA","entity_type":"gene"},{"created":"2024-03-22T14:28:51.965375+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2428","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hexa has been classified as Green List (High Evidence).","entity_name":"HEXA","entity_type":"gene"},{"created":"2024-03-22T14:28:48.524757+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2428","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HEXA were changed from  to GM2-gangliosidosis, several forms 272800; Tay-Sachs disease 272800","entity_name":"HEXA","entity_type":"gene"},{"created":"2024-03-22T14:28:23.363443+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2427","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: HEXA were set to ","entity_name":"HEXA","entity_type":"gene"},{"created":"2024-03-22T14:27:42.482354+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2426","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: HEXA was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"HEXA","entity_type":"gene"},{"created":"2024-03-22T14:26:35.024344+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2425","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HEPACAM as ready","entity_name":"HEPACAM","entity_type":"gene"},{"created":"2024-03-22T14:26:35.012498+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2425","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hepacam has been classified as Green List (High Evidence).","entity_name":"HEPACAM","entity_type":"gene"},{"created":"2024-03-22T14:26:30.605762+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2425","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HEPACAM were changed from  to Megalencephalic leukoencephalopathy with subcortical cysts 2A, MIM# 613925; Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation, MIM# 613926","entity_name":"HEPACAM","entity_type":"gene"},{"created":"2024-03-22T14:25:56.530201+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2424","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: HEPACAM were set to ","entity_name":"HEPACAM","entity_type":"gene"},{"created":"2024-03-22T14:25:24.092306+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2423","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: HEPACAM was changed from Unknown to BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal","entity_name":"HEPACAM","entity_type":"gene"},{"created":"2024-03-22T14:22:58.125562+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2422","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HAX1 as ready","entity_name":"HAX1","entity_type":"gene"},{"created":"2024-03-22T14:22:58.115195+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2422","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hax1 has been classified as Green List (High Evidence).","entity_name":"HAX1","entity_type":"gene"},{"created":"2024-03-22T14:22:53.569784+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2422","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HAX1 were changed from  to Neutropaenia, severe congenital 3, autosomal recessive, MIM# 610738; Kostmann syndrome MONDO:0012548","entity_name":"HAX1","entity_type":"gene"},{"created":"2024-03-22T14:22:16.782290+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2421","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: HAX1 were set to ","entity_name":"HAX1","entity_type":"gene"},{"created":"2024-03-22T14:21:44.955271+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2420","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: HAX1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"HAX1","entity_type":"gene"},{"created":"2024-03-22T14:20:35.638726+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2419","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GOSR2 as ready","entity_name":"GOSR2","entity_type":"gene"},{"created":"2024-03-22T14:20:35.628579+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2419","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gosr2 has been classified as Green List (High Evidence).","entity_name":"GOSR2","entity_type":"gene"},{"created":"2024-03-22T14:20:26.637434+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2419","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GOSR2 were changed from  to Epilepsy, progressive myoclonic 6 , MIM#614018","entity_name":"GOSR2","entity_type":"gene"},{"created":"2024-03-22T14:19:44.809124+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2418","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GOSR2 were set to ","entity_name":"GOSR2","entity_type":"gene"},{"created":"2024-03-22T14:18:22.553237+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2417","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GOSR2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GOSR2","entity_type":"gene"},{"created":"2024-03-22T14:17:33.325028+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2416","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GNAQ as ready","entity_name":"GNAQ","entity_type":"gene"},{"created":"2024-03-22T14:17:33.311699+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2416","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gnaq has been classified as Green List (High Evidence).","entity_name":"GNAQ","entity_type":"gene"},{"created":"2024-03-22T14:17:29.092834+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2416","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GNAQ were changed from  to Sturge-Weber syndrome, somatic, mosaic 185300","entity_name":"GNAQ","entity_type":"gene"},{"created":"2024-03-22T14:16:58.729428+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2415","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GNAQ were set to ","entity_name":"GNAQ","entity_type":"gene"},{"created":"2024-03-22T14:16:32.374753+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2414","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of pathogenicity for gene: GNAQ was changed from  to Other","entity_name":"GNAQ","entity_type":"gene"},{"created":"2024-03-22T14:15:58.764798+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2413","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GNAQ was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GNAQ","entity_type":"gene"},{"created":"2024-03-22T14:15:38.960106+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2412","user_name":"Zornitza Stark","item_type":"entity","text":"Tag somatic tag was added to gene: GNAQ.","entity_name":"GNAQ","entity_type":"gene"},{"created":"2024-03-22T14:14:43.613579+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2412","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GM2A as ready","entity_name":"GM2A","entity_type":"gene"},{"created":"2024-03-22T14:14:43.606541+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2412","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gm2a has been classified as Green List (High Evidence).","entity_name":"GM2A","entity_type":"gene"},{"created":"2024-03-22T14:14:39.696617+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2412","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GM2A were changed from  to GM2-gangliosidosis, AB variant MIM#272750","entity_name":"GM2A","entity_type":"gene"},{"created":"2024-03-22T14:14:08.600481+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2411","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GM2A were set to ","entity_name":"GM2A","entity_type":"gene"},{"created":"2024-03-22T14:13:30.888739+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2410","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GM2A was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GM2A","entity_type":"gene"},{"created":"2024-03-22T14:12:28.567392+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2409","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GLUL as ready","entity_name":"GLUL","entity_type":"gene"},{"created":"2024-03-22T14:12:28.556813+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2409","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: glul has been classified as Green List (High Evidence).","entity_name":"GLUL","entity_type":"gene"},{"created":"2024-03-22T14:12:24.232931+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2409","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GLUL were changed from  to Glutamine deficiency, congenital MIM#610015","entity_name":"GLUL","entity_type":"gene"},{"created":"2024-03-22T14:11:53.848369+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2408","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GLUL were set to ","entity_name":"GLUL","entity_type":"gene"},{"created":"2024-03-22T14:11:20.991768+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2407","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GLUL was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GLUL","entity_type":"gene"},{"created":"2024-03-22T14:10:43.368889+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2406","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GLUL: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Glutamine deficiency, congenital MIM#610015; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"GLUL","entity_type":"gene"},{"created":"2024-03-22T14:09:41.292857+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2406","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GLUD1 as ready","entity_name":"GLUD1","entity_type":"gene"},{"created":"2024-03-22T14:09:41.285264+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2406","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: glud1 has been classified as Green List (High Evidence).","entity_name":"GLUD1","entity_type":"gene"},{"created":"2024-03-22T14:09:37.291850+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2406","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GLUD1 were changed from  to Hyperinsulinism-hyperammonemia syndrome, MIM# 606762","entity_name":"GLUD1","entity_type":"gene"},{"created":"2024-03-22T14:09:00.580298+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2405","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GLUD1 were set to ","entity_name":"GLUD1","entity_type":"gene"},{"created":"2024-03-22T14:08:28.636752+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2404","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GLUD1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GLUD1","entity_type":"gene"},{"created":"2024-03-22T14:07:51.410311+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2403","user_name":"Zornitza Stark","item_type":"entity","text":"changed review comment from: Well established gene-disease association.; to: Well established gene-disease association. Hypoglycaemic seizures.","entity_name":"GLUD1","entity_type":"gene"},{"created":"2024-03-22T14:06:24.678127+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2403","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GLDC as ready","entity_name":"GLDC","entity_type":"gene"},{"created":"2024-03-22T14:06:24.667925+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2403","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gldc has been classified as Green List (High Evidence).","entity_name":"GLDC","entity_type":"gene"},{"created":"2024-03-22T14:06:20.273167+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2403","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GLDC were changed from  to Glycine encephalopathy (MIM#605899)","entity_name":"GLDC","entity_type":"gene"},{"created":"2024-03-22T14:05:38.751106+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2402","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GLDC were set to ","entity_name":"GLDC","entity_type":"gene"},{"created":"2024-03-22T14:05:01.233583+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2401","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GLDC was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GLDC","entity_type":"gene"},{"created":"2024-03-22T14:04:06.475188+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2400","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GLB1 as ready","entity_name":"GLB1","entity_type":"gene"},{"created":"2024-03-22T14:04:06.464940+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2400","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: glb1 has been classified as Green List (High Evidence).","entity_name":"GLB1","entity_type":"gene"},{"created":"2024-03-22T14:04:01.971485+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2400","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GLB1 were changed from  to GM1-gangliosidosis, type I MIM#230500; GM1-gangliosidosis, type II MIM# 230600","entity_name":"GLB1","entity_type":"gene"},{"created":"2024-03-22T14:02:38.764344+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2399","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GLB1 were set to ","entity_name":"GLB1","entity_type":"gene"},{"created":"2024-03-22T14:02:06.589943+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2398","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GLB1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GLB1","entity_type":"gene"},{"created":"2024-03-22T14:01:09.415656+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2397","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GFM1 as ready","entity_name":"GFM1","entity_type":"gene"},{"created":"2024-03-22T14:01:09.407746+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2397","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gfm1 has been classified as Green List (High Evidence).","entity_name":"GFM1","entity_type":"gene"},{"created":"2024-03-22T14:01:06.465572+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2397","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GFM1 were changed from  to Combined oxidative phosphorylation deficiency 1 MIM#609060","entity_name":"GFM1","entity_type":"gene"},{"created":"2024-03-22T14:00:33.654210+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2396","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GFM1 were set to ","entity_name":"GFM1","entity_type":"gene"},{"created":"2024-03-22T14:00:02.354707+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2395","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GFM1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GFM1","entity_type":"gene"},{"created":"2024-03-22T13:58:30.729414+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2394","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GFAP as ready","entity_name":"GFAP","entity_type":"gene"},{"created":"2024-03-22T13:58:30.718108+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2394","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gfap has been classified as Green List (High Evidence).","entity_name":"GFAP","entity_type":"gene"},{"created":"2024-03-22T13:58:27.203554+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2394","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GFAP were changed from  to Alexander disease, MIM#\t203450","entity_name":"GFAP","entity_type":"gene"},{"created":"2024-03-22T13:57:34.266525+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.2393","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GFAP were set to ","entity_name":"GFAP","entity_type":"gene"}]}